1
|
Sempoux C, Jibara G, Ward SC, Fan C, Qin
L, Roayaie S, Fiel MI, Schwartz M and Thung SN: Intrahepatic
cholangiocarcinoma: New insights in pathology. Semin Liver Dis.
31:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Khan SA, Taylor-Robinson SD, Toledano MB,
Beck A, Elliott P and Thomas HC: Changing international trends in
mortality rates for liver, biliary and pancreatic tumours. J
Hepatol. 37:806–813. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nakanuma Y, Sasaki M, Ikeda H, Sato Y, Zen
Y, Kosaka K and Harada K: Pathology of peripheral intrahepatic
cholangiocarcinoma with reference to tumorigenesis. Hepatol Res.
38:325–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
The general rules for the clinical and
pathological study of primary liver cancer. Liver cancer study
group of Japan. Jpn J Surg. 19:98–129. 1989. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ohtsuka M, Ito H, Kimura F, Shimizu H,
Togawa A, Yoshidome H and Miyazaki M: Results of surgical treatment
for intrahepatic cholangiocarcinoma and clinicopathological factors
influencing survival. Br J Surg. 89:1525–1531. 2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wu ZF, Zhang HB, Yang N, Zhao WC, Fu Y and
Yang GS: Postoperative adjuvant transcatheter arterial
chemoembolisation improves survival of intrahepatic
cholangiocarcinoma patients with poor prognostic factors: Results
of a large monocentric series. Eur J Surg Oncol. 38:602–610. 2012.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127:S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tretiakova MS, Shabani-Rad MT, Guggisberg
K, Hart J, Anders RA and Gao ZH: Genomic and immunophenotypical
differences between hepatocellular carcinoma with and without
cirrhosis. Histopathology. 56:683–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Paquet KJ, Gad HA, Lazar A, Koussouris P,
Mercado MA, Heine WD, Jachman-Jahn V and Ruppert W: Analysis of
factors affecting outcomes after hepatectomy of patients with liver
cirrhosis and small hepatocellular carcinoma. Eur J Surg.
164:513–519. 1998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bréchot C: Pathogenesis of hepatitis B
virus-related hepatocellular carcinoma: Old and new paradigms.
Gastroenterology. 127 (5 Suppl 1):S56–S61. 2004. View Article : Google Scholar : PubMed/NCBI
|
12
|
Perumal V, Wang J, Thuluvath P, Choti M
and Torbenson M: Hepatitis C and hepatitis B nucleic acids are
present in intrahepatic cholangiocarcinomas from the United States.
Hum Pathol. 37:1211–1216. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF
and Hsieh SY: Viral hepatitis-associated intrahepatic
cholangiocarcinoma shares common disease processes with
hepatocellular carcinoma. Br J Cancer. 100:1765–1770. 2009.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Palmer WC and Patel T: Are common factors
involved in the pathogenesis of primary liver cancers? A
meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
J Hepatol. 57:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shaib YH, El-Serag HB, Davila JA, Morgan R
and McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in
the United States: A case-control study. Gastroenterology.
128:620–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Pandey D, Lee KH, Wai CT, Wagholikar G and
Tan KC: Long term outcome and prognostic factors for large
hepatocellular carcinoma (10 cm or more) after surgical resection.
Ann Surg Oncol. 14:2817–2823. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Poon RT, Fan ST, Lo CM, Liu CL, Ng IO and
Wong J: Long-term prognosis after resection of hepatocellular
carcinoma associated with hepatitis B-related cirrhosis. J Clin
Oncol. 18:1094–1101. 2000. View Article : Google Scholar : PubMed/NCBI
|
18
|
Peng NF, Li LQ, Qin X, Guo Y, Peng T, Xiao
KY, Chen XG, Yang YF, Su ZX, Chen B, et al: Evaluation of risk
factors and clinicopathologic features for intrahepatic
cholangiocarcinoma in Southern China: A possible role of hepatitis
B virus. Ann Surg Oncol. 18:1258–1266. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang L, Cai JQ, Zhao JJ, Bi XY, Tan XG,
Yan T, Li C and Zhao P: Impact of hepatitis B virus infection on
outcome following resection for intrahepatic cholangiocarcinoma. J
Surg Oncol. 101:233–238. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Luo X, Yuan L, Wang Y, Ge R, Sun Y and Wei
G: Survival outcomes and prognostic factors of surgical therapy for
all potentially resectable intrahepatic cholangiocarcinoma: A large
single-center cohort study. J Gastrointest Surg. 18:562–572. 2014.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Li YY, Li H, Lv P, Liu G, Li XR, Tian BN
and Chen DJ: Prognostic value of cirrhosis for intrahepatic
cholangiocarcinoma after surgical treatment. J Gastrointest Surg.
15:608–613. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Scheuer PJ: Classification of chronic
viral hepatitis: A need for reassessment. J Hepatol. 13:372–374.
1991. View Article : Google Scholar : PubMed/NCBI
|
23
|
Strasberg SM: Nomenclature of hepatic
anatomy and resections: A review of the Brisbane 2000 system. J
Hepatobiliary Pancreat Surg. 12:351–355. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Farges O, Fuks D, Boleslawski E, Le Treut
YP, Castaing D, Laurent A, Ducerf C, Rivoire M, Bachellier P,
Chiche L, et al: Influence of surgical margins on outcome in
patients with intrahepatic cholangiocarcinoma: A multicenter study
by the AFC-IHCC-2009 study group. Ann Surg. 254:824–830. 2011.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Hou J, Liu Z and Gu F: Epidemiology and
prevention of hepatitis B virus infection. Int J Med Sci. 2:50–57.
2005. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ,
Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, et al: Intrahepatic
cholangiocarcinoma: Report of 272 patients compared with 5,829
patients with hepatocellular carcinoma. J Cancer Res Clin Oncol.
135:1073–1080. 2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Xu J, Igarashi S, Sasaki M, Matsubara T,
Yoneda N, Kozaka K, Ikeda H, Kim J, Yu E, Matsui O and Nakanuma Y:
Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in
comparison with those in normal livers. Liver Int. 32:1156–1164.
2012. View Article : Google Scholar : PubMed/NCBI
|